|
"shan ys"的相關文件
顯示項目 71-80 / 133 (共14頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2019-07 |
Protein arginine methyltransferase 3-induced metabolic reprogramming is a vulnerable target of pancreatic cancer
|
Hsu, MC;Tsai, YL;Lin, CH;Pan, MR;Shan, YS;Cheng, TY;Cheng, SHC;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2019-05-20 |
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
|
Weng, CC;Hsieh, MJ;Wu, CC;Lin, YC;Shan, YS;Hung, WC;Chen, LT;Cheng, KH |
| 國家衛生研究院 |
2019-02 |
Mutational landscape by targeted next-generation sequencing in EBV-associated lymphoepithelioma-like cholangiocarcinoma
|
Chiang, NJ;Chen, MH;Chen, LT;Shan, YS |
| 國家衛生研究院 |
2019-01 |
Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer
|
Kuo, TL;Cheng, KH;Shan, YS;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2018-12-20 |
Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression
|
Hsu, MC;Pan, MR;Chu, PY;Tsai, YL;Tsai, CH;Shan, YS;Chen, LT;Hung, WC |
| 國家衛生研究院 |
2018-12 |
c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
|
Chang, TM;Shan, YS;Chu, PY;Lin, HY;Huang, KW;Hung, WC;Chen, LT;Tsai, HJ |
| 國家衛生研究院 |
2018-12 |
The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan
|
Tsai, HJ;Chang, JS;Shan, YS;Tsai, CR;Chen, LT |
| 國家衛生研究院 |
2018-11-07 |
Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial
|
Chen, LT;Siveke, JT;Wang-Gillam, A;Li, CP;Bodoky, G;Dean, AP;Shan, YS;Jameson, GS;Macarulla, T;Lee, KH;Cunningham, D;Blanc, JF;Chiu, CF;Schwartsmann, G;Braiteh, FS;Mamlouk, K;Belanger, B;de Jong, FA;Hubner, RA |
| 國家衛生研究院 |
2018-11 |
TCOG T1308 study: The final results of a phase II trial of modified gemcitabine plus S-1 combination as the first-line treatment in patients with advanced biliary tract cancer
|
Chiang, NJ;Chen, LT;Chen, JS;Yang, SH;Hsu, C;Shan, YS;Yen, CJ;Chen, MH;Tsou, HH |
| 國家衛生研究院 |
2018-10 |
Multicenter, phase II trial of biweekly S-1, leucovorin (LV), oxaliplatin and gemcitabine (SLOG) in metastatic pancreatic adenocarcinoma (mPDAC): Final report of TCOG T1211 study
|
Chiang, NJ;Tsai, KK;Chen, JS;Yang, SH;Hsiao, HH;Shan, YS;Chen, LT |
顯示項目 71-80 / 133 (共14頁)
<< < 3 4 5 6 7 8 9 10 11 12 > >>
每頁顯示[10|25|50]項目
|
